40 Stocks Moving In Thursday's Mid-Day Session

Gainers

• Ebang International Holdings Inc. EBON shares gained 80.5% to $14.42. Ebang International, last month, established a subsidiary in Singapore in preparation for establishing a cryptocurrency exchange.
• Enservco Corporation ENSV jumped 72.7% to $0.22 after the company signed a non-binding letter of intent with lender to amend its senior revolving credit facility. The company said bank debt would be reduced from approximately $33 million to approximately $17 million.
• Just Energy Group Inc. JE shares jumped 32.7% to $0.2840 as the company issued an update for closing of plan of arrangement.
• Herman Miller, Inc. MLHR surged 29.3% to $33.47 after the company reported a strong rise in its earnings for its fiscal first quarter. The company’s sales also exceeded analysts’ estimates.
• Sorrento Therapeutics, Inc. SRNE gained 22.1% to $10.21. TheSan Diego, California-based biopharma said the FDA has given its nod for initiating a Phase 1 trial for COVI-GUARD, its stand-alone antibody therapy aimed at blocking viral entry into host cells, in hospitalized COVID-19 patients.
• Northern Dynasty Minerals Ltd. NAK gained 21.8% to $1.1650 after declining around 4% on Wednesday.
• Town Sports International Holdings, Inc. CLUB jumped 21.6% to $0.3209. Town Sports International recently filed voluntary petitions for relief under Chapter 11 bankruptcy.
• Vaccinex, Inc. VCNX climbed 20.8% to $6.39 after the company announced a clinical collaboration with Merck to evaluate Pepinemab in combination with KEYTRUDA in advanced, recurrent or metastatic head and neck squamous cell carcinoma.
• Vaxart, Inc. VXRT rose 17.2% to $8.65. Vaxart shares jumped around 14% on Wednesday as traders circulated European Patent Office registration for 'Formulations for Small Intestinal Delivery of Rsv and Norovirus Antigens.'
• Phio Pharmaceuticals Corp. PHIO gained 16.4% to $2.491.
• 51job, Inc. JOBS shares rose 16.2% to $79.16 after the company said it received a primary non-binding proposal from DCP Capital Partners to acquire the company for $79.05 per share.
• Envela Corporation ELA gained 16.1% to $4.9350. Envela recently said it expects Q3 revenue to exceed $33 million based on quarter-to-date trends.
• iBio, Inc. IBIO rose 14.2% to $2.4550 after gaining 7% on Wednesday. iBio recently selected IBIO-201 as its leading candidate for the prevention of SARS-CoV-2 infection.
• OncoSec Medical Incorporated ONCS gained 13.5% to $4.46 after gaining 15% on Wednesday.
• Cardiff Oncology, Inc. CRDF surged 13.3% to $6.59. Cardiff Oncology highlighted presentation of data at ESMO 'confirming efficacy of onvansertib and durability of response in KRAS-mutated metastatic colorectal cancer (mCRC).' A Form 4 filing filed with the SEC on Wednesday, September 16 showed that Pace Gary W bought 850 shares at an average price of $5.71.
• Alterity Therapeutics Limited ATHE gained 12.8% to $2.29. The company ahas been granted U.S. patent office titled 'Compounds for and Methods of Treating Diseases.'
• Steelcase Inc. SCS rose 11.8% to $12.06. Steelcase is expected to report quarterly results on September 23.
• Esports Entertainment Group, Inc. GMBL surged 11.1% to $4.345. Esports Entertainment recently said it sees FY21 sales of $13 million and FY22 sales of $25 million.
• Knoll, Inc. KNL rose 9.5% to $12.60 in pre-market trading.
• American Virtual Cloud Technologies, Inc. AVCT rose 8.6% to $4.42 after the company named Xavier Williams as new CEO.
• AnPac Bio-Medical Science Co., Ltd. ANPC rose 8.2% to $5.30. AnPac Bio said, in mid August, it entered into immunology testing contract with Beijing Yuan Jian Health.
• Gridsum Holding Inc. GSUM gained 7.3% to $1.17 after rising around 4% on Wednesday.
• Newgioco Group, Inc. NWGI rose 6.2% to $1.7416. Newgioco recently obtained GLI-33 certification to launch Elys Sportsbook platform in the U.S.
• Gevo, Inc. GEVO rose 6% to $0.9320. Gevo, yesterday, said it was granted Australian patent number 2015332509 titled 'Methods for conversion of ethanol to functionalized lower hydrocarbons and downstream hydrocarbons.'

Check out these big penny stock gainers and losers

Losers

• The Marcus Corporation MCS shares dipped 29.7% to $9.57 after the company reported the launch of $87 million convertible senior notes offering.
• Dave & Buster's Entertainment, Inc. PLAY dropped 20.4% to $15.22 on a report that noted the company may need to file for bankruptcy if it can't reach a deal with its lenders.
• Strongbridge Biopharma plc SBBP fell 19% to $2.27 after the company said that it intends to offer ordinary shares in an underwritten public offering.
• Nano-X Imaging Ltd. NNOX dropped 15.8% to $30.99 following reports that hedge fund manager Whitney Tilson has made cautious comments on the company’s stock.
• Checkpoint Therapeutics, Inc. CKPT fell 14% to $3.6450 after announcing positive interim results from registration-enabling trial of cosibelimab in metastatic cutaneous squamous cell carcinoma.
• Forterra, Inc. FRTA fell 13.2% to $12.68. Forterra recently announced secondary offering of 10 million shares and also reported voluntary prepayment of term loan.
• Anterix Inc. ATEX dropped 12.6% to $40.49.
• Inovio Pharmaceuticals, Inc. INO shares fell 11.4% to $16.41 after surging 36% on Wednesday. Inovio Pharmaceuticals presented at the H.C. Wainwright 22nd Annual Global Investor Conference on Monday.
• NuCana plc NCNA fell 11.3% to $5.05 after the company priced its 15.56 million ADS offering at $4.50 per ADS.
• Cardlytics, Inc. CDLX dipped 11.1% to $64.11 after the company reported a proposed private offering of $200 million of convertible senior notes.
• Cerence Inc. CRNC dropped 10.8% to $54.95. Cerence recently reported that Volkswagen has selected the company to power voice control in new fully electric ID.3.
• First Solar, Inc. FSLR dropped 9.9% to $64.84 after the company reported secondary offering of 8.6 million shares at a price of $69.00 per share.
• Plus Therapeutics, Inc. PSTV fell 9.3% to $2.8470. Plus Therapeutics recently received Fast Track designation from the FDA for its glioblastoma treatment.
• Novus Therapeutics, Inc. NVUS shares fell 7.7% to $0.9234 after declining 10% on Wednesday. Novus Therapeutics, on Tuesday, reported the acquisition of Anelixis Therapeutics, Inc., a privately held clinical-stage biotechnology company developing a next generation anti-CD40 Ligand antibody as a potential treatment for organ and cellular transplantation, autoimmune diseasesand neurodegenerative diseases.
• Snowflake Inc SNOW fell 7.3% to $235.37. Snowflake shares surged 112% on Wednesday after the company priced its IPO at $120 per share.
• Chewy Inc CHWY fell 3.3% to $54.32 after the company reported a public offering of $275 million of shares of its Class A common stock.